Consideration of short-term carcinogenicity tests using transgenic mouse models

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 403, Issue 1-2, 1998, Pages 259-263

  Blain, Peter G ^a   Battershill, Jon M ^b   Venitt, Stanley ^c   Cooper, Colin C ^c   Fielder, Robin J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Skipton House ^*  (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Carcinogenicity testing; Transgenic mouse

Indexed keywords

CARCINOGEN;

CANCER MODEL; CARCINOGEN TESTING; CARCINOGENICITY; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0032541152     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00026-8     Document Type: Article

References (13)

1. [1] ICH, International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for human use (ICH), Harmonised Tripartite Guideline, Testing for Carcinogenicity of Pharmaceuticals, 1997.
2. [2] R.W. Tennnant, J. Spalding, J.E. French, Evaluation of transgenic mouse bioassays for identifying carcinogens and non-carcinogens, Mutat. Res. 365 (1996) 119-127.
3. [3] S. Yamamoto, K. Mitsumori, Y. Kodama, N. Matsunuma, S. Manabe, H. Okamiya, H. Suzuki, T. Fukuda, Y. Sakamaki, M. Sunaga, G. Nomura, K. Hioki, S. Wakana, T. Nomura, Y. Hayashi, Rapid induction of more malignant tumours by various genotoxic carcinogens in transgenic mice harbouring a human prototype c-Ha-ras gene than in control non-transgenic mice, Carcinogenesis 17 (11) (1996) 2455-2461.
4. [4] R.J.W. Berg, A. de Vries, H. van Steeg, F.R. de Grujl, Relative susceptibilities of XPA knockout mice and their heterozygous and wild type littermates to UVB-induced skin cancer, Cancer Res. 57 (1997) 581-584.
5. [5] J.W. Spalding, J. Momma, M.R. Elwell, R.W. Tennant, Chemical induced skin carcinogenesis in transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene, Carcinogenesis 14 (1993) 1335-1341.
6. [6] T. Lyon, Carcinogenesis in transgenic mouse models, Environ. Health Perspect. 105 (1997) 912-913.
7. [7] J. Ashby, D. Paton, Chemicals for evaluating the sensitivity and specificity of reduced/transgenic rodent cancer bioassay protocols, Mutat. Res. 331 (1995) 27-38.
8. [8] R.W. Tennant, J.E. French, J.W. Spalding, Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models, Environ. Health Perspect. 103 (1995) 942-950.
9. [9] National Toxicology Programme, Toxicology and carcinogenesis studies on N-methylolacrylamide in F344/N rats and B6C3F1 mice. NTP Technical report No. 352, US DHSS, NIH, 1989, pp. 204.
10. [10] J. Sakamoto, K. Hashimoto, Reproductive toxicity of acrylamide and related compounds in mice. Effects on fertility and sperm morphology, Arch. Toxicol. 59 (1986) 207-215.
11. [11] M. Balls, B.J. Blaauboer, J.H. Fentem, L. Bruner, R.D. Combes, B. Ekwall, R.J. Fielder, A. Guillouzo, R.W. Lewis, D.P. Lovell, C.A. Reinhardt, G. Repetto, D. Sladowski, H. Spielmann, F. Zucco, Practical aspects of the validation of toxicity test procedures, ECVAM Workshop report 5, ATLA, 23, 1995, pp. 129-147.
12. [12] L.S. Gold, T.H. Slone, B.N. Ames, Overview and update analysis of the carcinogenic potency database, in: L.S. Gold, E. Zeiger (Eds.), Handbook of Carcinogenic Potency and Genotoxicity Databases, CRC Press, New York, 1997, pp. 621-660.
13. [13] Department of Health, The 1997 Joint Report of the Committees on Toxicity, Mutagenicity and Carcinogenicity of Chemicals in Food, Consumer Products and the Environment, London, HMSO, 1998, in press.